ArticleFrontiers in immunology2021

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.

Sarah Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.